JPH10500989A - 5ht1a拮抗薬としてのピペラジン誘導体 - Google Patents
5ht1a拮抗薬としてのピペラジン誘導体Info
- Publication number
- JPH10500989A JPH10500989A JP8500531A JP50053196A JPH10500989A JP H10500989 A JPH10500989 A JP H10500989A JP 8500531 A JP8500531 A JP 8500531A JP 50053196 A JP50053196 A JP 50053196A JP H10500989 A JPH10500989 A JP H10500989A
- Authority
- JP
- Japan
- Prior art keywords
- methyl
- formula
- hydrogen
- compound
- pyridyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, ***e
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1.一般式A: [式中、RaおよびRbはそれぞれ水素またはメチル、Rcは水素、ハロまたはC1 -4 アルキルである] で示される化合物またはその医薬上許容される酸付加塩。 2.Rcが水素である請求項1記載の化合物。 3.(R)−N−(1−メチル−2−(4−インドリル−1−ピペラジニルエ チル)−N−(2−ピリジル)シクロヘキサンカルボキサミドまたはその医薬上 許容される酸付加塩。 4.(R)−N−(2−メチル−(4−インドリル−1−ピペラジニル)エチ ル)−N−(2−(ピリジル)シクロヘキサンカルボキサミドまたはその医薬上 許容される酸付加塩。 5.N−[2−(4−(4−インドリル)−1−ピペラジニル)エチル]−N −(2−ピリジル)シクロヘキサンカルボキサミドまたはその医薬上許容される 酸付加塩。 6.前記請求項のいずれか1項記載の化合物を医薬上許容される希釈剤または 担体と組み合わせてなる医薬組成物。 7.CNS障害の治療における求項1〜5のいずれか1項記載の化合物の使用 。 8.CNS障害の治療用医薬品の製造における請求項1〜5のいずれか1項記 載の化合物の使用。 9.治療を必要とする哺乳動物に有効量の請求項1〜5のいずれか1項記載の 化合物を投与することによってCNS障害を治療する方法。 10.式B: [式中、RaおよびRbはそれぞれ水素またはメチルである] で示されるアミン。 11.式B: [式中、RaおよびRbはそれぞれ水素またはメチルである] で示されるアミンを、シクロヘキサンカルボン酸またはそのアシル化誘導体でア シル化することからなる請求項2〜5いずれか1項記載の化合物を製造する方法 。 12.式: で示されるアミドを、式: [式中、RaおよびRbはそれぞれ水素またはメチル、X1はハロゲンまたはアル キル−もしくはアリール−スルホニルオキシ基などの脱離基である] で示されるアルキル化剤でアルキル化することからなる請求項2〜5いずれか1 項記載の化合物を製造する方法。 13.式C: で示される化合物を、式 [式中、RaおよびRbはそれぞれ水素またはメチル、X1はハロゲンまたはアル キル−またはアリール−スルホニルオキシ基のごとき脱離基である] で示される化合物でアルキル化することからなる請求項2〜5いずれか1項記載 の化合物を製造する方法。 14.式 で示される化合物のNind−保護化誘導体を2−フルオロピリジンN−オキシド と反応させ、続いて保護基およびN−オキシド基を除去することからなる請求項 2〜5のいずれか1項記載の化合物を製造する方法。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9411099.6 | 1994-06-03 | ||
GB9411099A GB9411099D0 (en) | 1994-06-03 | 1994-06-03 | Piperazine derivatives |
PCT/GB1995/001263 WO1995033743A1 (en) | 1994-06-03 | 1995-06-01 | Piperazine derivatives as 5ht1a antagonists |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH10500989A true JPH10500989A (ja) | 1998-01-27 |
Family
ID=10756114
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP8500531A Withdrawn JPH10500989A (ja) | 1994-06-03 | 1995-06-01 | 5ht1a拮抗薬としてのピペラジン誘導体 |
Country Status (25)
Country | Link |
---|---|
US (1) | US5723464A (ja) |
EP (1) | EP0763031B1 (ja) |
JP (1) | JPH10500989A (ja) |
KR (1) | KR100359393B1 (ja) |
CN (2) | CN1048985C (ja) |
AT (1) | ATE192744T1 (ja) |
AU (1) | AU680147B2 (ja) |
BR (1) | BR9507910A (ja) |
CA (1) | CA2191871C (ja) |
CZ (1) | CZ287381B6 (ja) |
DE (1) | DE69516867T2 (ja) |
DK (1) | DK0763031T3 (ja) |
ES (1) | ES2145275T3 (ja) |
FI (1) | FI114985B (ja) |
GB (1) | GB9411099D0 (ja) |
GR (1) | GR3033449T3 (ja) |
HU (1) | HUT76466A (ja) |
IL (1) | IL113967A (ja) |
MX (1) | MX9605915A (ja) |
NZ (2) | NZ331452A (ja) |
PT (1) | PT763031E (ja) |
RU (1) | RU2165933C2 (ja) |
SK (1) | SK281418B6 (ja) |
WO (1) | WO1995033743A1 (ja) |
ZA (1) | ZA954525B (ja) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007500751A (ja) * | 2003-06-11 | 2007-01-18 | ワイス | 二環式インドリル誘導体およびそのセロトニン作動薬としての使用法 |
JP2017537080A (ja) * | 2014-11-05 | 2017-12-14 | フレクサス・バイオサイエンシーズ・インコーポレイテッドFlexus Biosciences, Inc. | 免疫調節剤 |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU645681B2 (en) * | 1991-05-02 | 1994-01-20 | John Wyeth & Brother Limited | Piperazine derivatives |
DK0763024T3 (da) * | 1994-06-03 | 2002-12-02 | Wyeth John & Brother Ltd | Fremgangmåde og mellemprodukter til fremstilling af piperazinderivater |
CA2194984C (en) * | 1994-07-26 | 2002-07-02 | John Eugene Macor | 4-indole derivatives as serotonin agonists and antagonists |
US5486518A (en) * | 1995-04-10 | 1996-01-23 | American Home Products Corporation | 4-indolylpiperazinyl derivatives |
US5519025A (en) * | 1995-04-10 | 1996-05-21 | American Home Products Corporation | 4-indolylpiperazinyl derivatives |
IT1282705B1 (it) * | 1996-02-28 | 1998-03-31 | Recordati Chem Pharm | Uso di antagonisti del recettore serotoninergico 5-ht|a per il trattamento dell'incontinenza urinaria |
US5990114A (en) * | 1996-02-28 | 1999-11-23 | Recordati, S.A., Chemical And Pharmaceutical Company | Use of 5-HT1A receptor antagonists for the treatment of urinary incontinence |
DE19615232A1 (de) * | 1996-04-18 | 1997-10-23 | Merck Patent Gmbh | Neue Carbamoylderivate und deren Verwendung als 5-HT ¶1¶¶A¶-Antagonisten |
DE19725664A1 (de) * | 1997-06-18 | 1998-12-24 | Merck Patent Gmbh | 3-Benzylpiperidine |
US6399614B1 (en) | 1997-08-01 | 2002-06-04 | Recordati S.A. Chemical And Pharmaceutical Company | 1-(N-phenylaminoalkyl)piperazine derivatives substituted at position 2 of the phenyl ring |
US6271234B1 (en) | 1997-08-01 | 2001-08-07 | Recordati S.A., Chemical And Pharmaceutical Company | 1,4-disubstituted piperazines |
JP2001512110A (ja) * | 1997-08-01 | 2001-08-21 | レコルダチ エッセ.ア.,ケミカル アンド ファーマシューティカル カンパニー | 1,4−ジ置換ピペラジン |
IT1293807B1 (it) * | 1997-08-01 | 1999-03-10 | Recordati Chem Pharm | Derivati 1- (n-fenilaminoalchil) piperazinici sostituiti alla posizione 2 dell'anello fenilico |
IT1293804B1 (it) | 1997-08-01 | 1999-03-10 | Recordati Chem Pharm | Diarilalchilpiperazine attive sulle basse vie urinarie |
US6376494B1 (en) | 1998-06-15 | 2002-04-23 | American Home Products Corporation | Cycloalkyl-substituted aryl-piperazines, piperidines and tetrahydropyridines as serotonergic agents |
CN1312802A (zh) * | 1998-06-15 | 2001-09-12 | 美国家用产品公司 | 作为5-羟色胺能药物的环烷基取代的芳基哌嗪、哌啶和四氢吡啶 |
US20060223824A1 (en) | 2000-11-28 | 2006-10-05 | Wyeth | Serotonergic agents |
US20060287335A1 (en) | 2000-11-28 | 2006-12-21 | Wyeth | Serotonergic agents for treating sexual dysfunction |
JPWO2002070482A1 (ja) * | 2001-02-27 | 2004-07-02 | 鐘淵化学工業株式会社 | 光学活性n−アリール−1−アミノ−2−プロパノール誘導体の製造法 |
CN101492383A (zh) | 2002-03-12 | 2009-07-29 | 惠氏公司 | 制备手性1,4-二取代哌嗪的方法 |
US7091349B2 (en) | 2002-03-12 | 2006-08-15 | Wyeth | Process for synthesizing N-aryl piperazines with chiral N′-1-[benzoyl(2-pyridyl)amino]-2-propane substitution |
US7361773B2 (en) | 2002-03-12 | 2008-04-22 | Wyeth | Preparation of N1-(2'-pyridyl)-1,2-propanediamine sulfamic acid and its use in the synthesis of biologically active piperazines |
CN1982307A (zh) * | 2002-03-12 | 2007-06-20 | 惠氏公司 | 合成手性n-芳基哌嗪的方法 |
SI1483243T1 (sl) | 2002-03-12 | 2007-08-31 | Wyeth Corp | Priprava n1- (2'-piridil)-1,2-propandiamin sulfamske kisline in uporaba spojine za sintezo bioloĺ ko aktivnih piperazinov |
CN100436448C (zh) * | 2003-06-11 | 2008-11-26 | 惠氏公司 | 二环吲哚基衍生物以及其作为5-羟色胺能活性剂的应用 |
TW200800959A (en) | 2005-06-10 | 2008-01-01 | Wyeth Corp | Piperazine-piperidine antagonists and agonists of the 5-HT1a receptor |
US20080032965A1 (en) * | 2006-06-09 | 2008-02-07 | Hirst Warren D | Method for enhancing cognitive function |
CA2951259A1 (en) | 2014-06-06 | 2015-12-10 | Flexus Biosciences, Inc. | Immunoregulatory agents |
AR102537A1 (es) | 2014-11-05 | 2017-03-08 | Flexus Biosciences Inc | Agentes inmunomoduladores |
MX2017005462A (es) | 2014-11-05 | 2017-07-28 | Flexus Biosciences Inc | Agentes inmunorreguladores. |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8909209D0 (en) * | 1989-04-22 | 1989-06-07 | Wyeth John & Brother Ltd | Piperazine derivatives |
KR0173310B1 (ko) * | 1989-04-22 | 1999-02-01 | 폴 에이 리쳐 | 피페라진 유도체 |
GB9021535D0 (en) * | 1990-10-03 | 1990-11-14 | Wyeth John & Brother Ltd | Piperazine derivatives |
AU645681B2 (en) * | 1991-05-02 | 1994-01-20 | John Wyeth & Brother Limited | Piperazine derivatives |
SE9201138D0 (sv) * | 1992-04-09 | 1992-04-09 | Astra Ab | Novel phthalimidoalkylpiperazines |
GB9300195D0 (en) * | 1993-01-06 | 1993-03-03 | Wyeth John & Brother Ltd | Piperazine derivatives |
-
1994
- 1994-06-03 GB GB9411099A patent/GB9411099D0/en active Pending
-
1995
- 1995-06-01 ES ES95921017T patent/ES2145275T3/es not_active Expired - Lifetime
- 1995-06-01 SK SK1541-96A patent/SK281418B6/sk unknown
- 1995-06-01 RU RU97100151/04A patent/RU2165933C2/ru not_active IP Right Cessation
- 1995-06-01 PT PT95921017T patent/PT763031E/pt unknown
- 1995-06-01 EP EP95921017A patent/EP0763031B1/en not_active Expired - Lifetime
- 1995-06-01 DE DE69516867T patent/DE69516867T2/de not_active Expired - Fee Related
- 1995-06-01 KR KR1019960706880A patent/KR100359393B1/ko not_active IP Right Cessation
- 1995-06-01 WO PCT/GB1995/001263 patent/WO1995033743A1/en active IP Right Grant
- 1995-06-01 MX MX9605915A patent/MX9605915A/es not_active IP Right Cessation
- 1995-06-01 NZ NZ331452A patent/NZ331452A/xx unknown
- 1995-06-01 CN CN95193383A patent/CN1048985C/zh not_active Expired - Fee Related
- 1995-06-01 DK DK95921017T patent/DK0763031T3/da active
- 1995-06-01 IL IL11396795A patent/IL113967A/xx not_active IP Right Cessation
- 1995-06-01 CZ CZ19963507A patent/CZ287381B6/cs not_active IP Right Cessation
- 1995-06-01 HU HU9603315A patent/HUT76466A/hu unknown
- 1995-06-01 AT AT95921017T patent/ATE192744T1/de not_active IP Right Cessation
- 1995-06-01 NZ NZ287498A patent/NZ287498A/xx unknown
- 1995-06-01 AU AU26230/95A patent/AU680147B2/en not_active Ceased
- 1995-06-01 ZA ZA954525A patent/ZA954525B/xx unknown
- 1995-06-01 CA CA002191871A patent/CA2191871C/en not_active Expired - Fee Related
- 1995-06-01 JP JP8500531A patent/JPH10500989A/ja not_active Withdrawn
- 1995-06-01 BR BR9507910A patent/BR9507910A/pt not_active Application Discontinuation
- 1995-06-02 US US08/459,205 patent/US5723464A/en not_active Expired - Lifetime
-
1996
- 1996-12-02 FI FI964815A patent/FI114985B/fi active IP Right Grant
-
1998
- 1998-11-10 CN CN98122461A patent/CN1093122C/zh not_active Expired - Fee Related
-
2000
- 2000-05-19 GR GR20000401137T patent/GR3033449T3/el not_active IP Right Cessation
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007500751A (ja) * | 2003-06-11 | 2007-01-18 | ワイス | 二環式インドリル誘導体およびそのセロトニン作動薬としての使用法 |
JP2017537080A (ja) * | 2014-11-05 | 2017-12-14 | フレクサス・バイオサイエンシーズ・インコーポレイテッドFlexus Biosciences, Inc. | 免疫調節剤 |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH10500989A (ja) | 5ht1a拮抗薬としてのピペラジン誘導体 | |
AU683460B2 (en) | Propenoic acid derivatives | |
AU668413B2 (en) | Diaryl piperazinoacetamide compounds as antimuscarinic agents | |
JPH05508660A (ja) | ジアリールメチルピペリジンまたはピペラジンのピリジンおよびピリジンn−オキシド誘導体、並びにそれらの組成物および使用方法 | |
AU3869700A (en) | Imidazole compounds substituted with a six or seven membered heterocyclic ring containing two nitrogen atoms | |
JP2873025B2 (ja) | 1‐[モノ―もしくはビス(トリフルオロメチル)‐2‐ピリジニル]ピペラジンを含有する薬剤組成物 | |
TW200306830A (en) | N-[phenyl (piperidin-2-yl) methyl] benzamide derivatives, their preparation and their application in therapy | |
JP2000512623A (ja) | ドーパミンd▲下4▼レセプターアンタゴニストとしての2,4―ジアミノピリミジン誘導体 | |
JPH11509544A (ja) | ピペラジン誘導体および5−ht1a拮抗薬としてのそれらの使用 | |
JPH09500124A (ja) | 5‐ht1a受容体拮抗物質としてのn‐(ピペリジニル‐1‐アルキル)‐置換シクロヘキサンカルボン酸アミド | |
AU2021410119A1 (en) | Tetrahydroquinoline derivative and medicinal use thereof | |
JP2002527513A (ja) | ヒスタミン−h3アゴニストまたはアンタゴニストとしてのn−(イミダゾリルアルキル)置換環式アミン | |
JPH0747574B2 (ja) | ピリジン誘導体及びそれを有効成分とする向精神剤 | |
JP2003534332A (ja) | 1,4−ジアゼパン−2,5−ジオン誘導体、およびnk−1受容体アンタゴニストとしてのその使用 | |
JPH08501287A (ja) | アミド誘導体 | |
JPH08508031A (ja) | 5‐ht1aリガンドとしてのアミド誘導体 | |
JPH08507779A (ja) | 5‐ht1aリガンドとしてのアミド誘導体 | |
JPS59501458A (ja) | 2,5↓−ジアミノ↓−1,4↓−ジアゾ−ルの新規置換誘導体、その製法および該誘導体を含む薬理組成物 | |
JP2001511799A (ja) | オキシド−スクアレンシクラーゼ阻害剤として有用なヘテロ環式化合物 | |
JP3426601B2 (ja) | 新規なピリジル−およびピリミジルピペラジン誘導体 | |
JP2002501920A (ja) | セロトニン−1a受容体作動薬としてのオキサゾール誘導体 | |
US8530501B2 (en) | Salts and crystalline forms of a factor Xa inhibitor | |
JP3012048B2 (ja) | ピペラジン誘導体 | |
JP2001522835A (ja) | フェニル−アルキル−イミダゾール型のh3レセプターリガンド | |
KR970005300B1 (ko) | 락탐 유도체 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20060711 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20060704 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20061010 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20061127 |
|
A761 | Written withdrawal of application |
Free format text: JAPANESE INTERMEDIATE CODE: A761 Effective date: 20061221 |